- Home
- ATYR vs SRTS Comparison
ATYR vs SRTS Comparison
Compare ATYR & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | SRTS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 65.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ATYR | SRTS |
|---|---|---|
| Price | $0.84 | $4.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $3.67 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 948.2K | 41.9K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $3.03 |
| 52 Week High | $7.29 | $5.92 |
Technical Indicators
Market Signals| Indicator | ATYR | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 41.16 |
| Support Level | $0.68 | $3.66 |
| Resistance Level | $0.86 | $4.60 |
| Average True Range (ATR) | 0.05 | 0.28 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 68.00 | 18.33 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.